http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Sarepta Therapeutics Completes Enrollment in EMERGENE, a Phase 3 Clinical Study of SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E/R4
-
Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology
-
Image Protect Announces Change in Control Transaction
-
First Phosphate Signs Long-term Offtake Agreements and Pursues Interest from Financial Partner
-
Stratasys Publishes Third ESG and Sustainability Report; Advances Leadership in Sustainable Additive Manufacturing
-
Worksport Ltd. ($WKSP) Shares Enhanced Strategic Vision & Opportunity on New and Improved Investor Relations Website
-
Worksport Ltd. ($WKSP) Shares Enhanced Strategic Vision & Opportunity on New and Improved Investor Relations Website
-
Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC
-
Guardant Health (GH) Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
-
RevSpring's OmniBrain™ Access Now Available for Healthcare Providers
-
Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
-
Krystal Biotech (KRYS) Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer
-
OneSpan Inc. (OSPN) Appoints Ashish Jain as CTO
-
GE Appliances' "Elf-gineers" Adapt and Donate More Than 100 Toys for Kids With Disabilities
-
Golden Matrix Group (GMGI) Files for Ontario Gaming License
-
NV5 Global (NVEE) to Acquire Global Fire Protection Group
-
Dow achieves 24th year on the Dow Jones Sustainability World Index
-
Blueprint Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Railtown AI Joins AI Partnerships Corporation Affiliate Network
-
CrowdStrike Named a Leader in the 2024 GigaOm Radar Report for Container Security
-
Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome
-
NV5 Enters Agreement to Acquire Global Fire Protection Group; Expands Recurring Fire Safety Engineering Consulting and Design Services
-
Raadr (Doing Business as Telvantis) Announces $45 Million Working Capital Facility to Drive Accelerated Growth
-
Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA
-
Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer
-
St. Ann's Community Selects Toshiba for Managed Print
-
Ontario International Airport extended run of passenger increases to 45 straight months in November
-
OneSpan Appoints Identity Expert Ashish Jain as CTO
-
U.S. Economy Positioned for Growth as 2025 Economic Outlook Forecasts 4.7% Expansion in Equipment & Software Investment, 2.7% Increase in GDP
-
Ellen Sundra Joins Horizon3.ai as Vice President, Customers
-
Golden Matrix Group Inc. Files for Ontario Gaming License
-
Golden Matrix Group Inc. Files for Ontario Gaming License
-
Raadr (Doing Business as Telvantis) Announces $45 Million Working Capital Facility to Drive Accelerated Growth
-
Koin Credit Union and North Star Community Credit Union Enhance Member Experience with Mahalo’s Thoughtful Banking Platform
-
Mesoblast (MESO) Added to Nasdaq Biotechnology Index
-
LeddarTech Reports FY24 Results
-
Mesoblast to be Added to Nasdaq Biotechnology Index
-
Valour Digital Securities Limited and The Hashgraph Group (THG) Expand Access to Hedera HBAR ETP with Euronext Listing
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Cara Therapeutics (CARA) and Tvardi Therapeutics Announce Entry into Merger Agreement
-
Esperion Therapeutics (ESPR) Strengthens Balance Sheet with Closing of Significant Refinancing Transactions
-
LiveOne’s (Nasdaq: LVO) Partnership with Tesla Surpasses 350K Paid Subscribers; Reports $16M Current Cash Position
-
Game Changing AI Applications from Healthcare to Marketing to Gaming
-
ScaleReady awards a G-Rex® Grant to Moonlight Bio
-
Explorance Announces Appointment of General Manager of Enterprise Solutions & Thought Leadership
-
Esperion Strengthens Balance Sheet with Closing of Significant Refinancing Transactions
-
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024
-
Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement
-
Viatris Inc (VTRS) Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology
-
Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology


